Plasmodium falciparum: multifaceted resistance to artemisinins
about
Artemisinin Action and Resistance in Plasmodium falciparumPlasmodium falciparum GFP-E-NTPDase expression at the intraerythrocytic stages and its inhibition blocks the development of the human malaria parasiteAbsence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in UgandaIn vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate.Polymeric therapeutic delivery systems for the treatment of infectious diseases.Protein Degradation Systems as Antimalarial Therapeutic Targets.Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia.Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism.Activities of 11-Azaartemisinin and N-Sulfonyl Derivatives against Asexual and Transmissible Malaria Parasites.Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance.Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.Altered life history strategies protect malaria parasites against drugs.Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016.Repurposing drugs to target the malaria parasite unfolding protein response.Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte StagesPopulation Pharmacokinetics of the Antimalarial Amodiaquine: A Pooled Analysis to Optimize Dosing
P2860
Q28276294-F84361C9-5522-492B-B78E-D599803CBAB1Q30041136-FE566F51-FC5B-4DB9-A514-B6D376B55956Q37576425-13652A00-A1F1-4D0C-99A2-D4D36AE0DE46Q37607795-9B4D01D4-43D1-43F3-87C9-83F1579F0AE9Q39386505-4BA1975D-B9A8-4CCE-9C16-7DDDEBE92EABQ39422863-656C4138-C0DA-4258-9710-876873136926Q47100748-512F0E46-0769-4A09-BFBD-C91AF961D38BQ47362967-0B045A06-C2EF-4FF9-9566-D02502936D6EQ48018805-FF16089B-7B9F-4D2A-B457-5CA9708B9017Q48023117-2E20BF1B-A675-48E8-83D9-BCD3D18A8209Q52575118-FBEAE827-2440-4FA3-A1E0-EA64D356B61FQ53696597-55C79390-5447-45C5-8AB1-4069E1CC5EBFQ53701065-997C94AC-E053-4D21-BB24-592EB52C5624Q55560161-5DBF801D-1D31-402A-94C2-A015143F237EQ56355670-3F1F7AD9-4473-4D6A-8F6A-3D56C206DA1DQ56358106-F69B78AC-DF58-4E39-BEE2-47F115FFDF12
P2860
Plasmodium falciparum: multifaceted resistance to artemisinins
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Plasmodium falciparum: multifaceted resistance to artemisinins
@ast
Plasmodium falciparum: multifaceted resistance to artemisinins
@en
Plasmodium falciparum: multifaceted resistance to artemisinins
@nl
type
label
Plasmodium falciparum: multifaceted resistance to artemisinins
@ast
Plasmodium falciparum: multifaceted resistance to artemisinins
@en
Plasmodium falciparum: multifaceted resistance to artemisinins
@nl
prefLabel
Plasmodium falciparum: multifaceted resistance to artemisinins
@ast
Plasmodium falciparum: multifaceted resistance to artemisinins
@en
Plasmodium falciparum: multifaceted resistance to artemisinins
@nl
P2093
P2860
P921
P1433
P1476
Plasmodium falciparum: multifaceted resistance to artemisinins
@en
P2093
Arba P. Ramadani
Françoise Benoit-Vical
Jean-Michel Augereau
P2860
P2888
P356
10.1186/S12936-016-1206-9
P407
P5008
P577
2016-03-09T00:00:00Z
P5875
P6179
1031202001